Background: Some patients develop asthmatic symptoms such as wheezing and dyspnea during the course of cough variant asthma (CVA), which are considered precursors of classical asthma.
Objectives: To identify the characteristics of such patients, we investigated the nature of CVA patients with or without developing bronchial asthma in the longitudinal study.
Methods: In 28 CVA patients whom we could observe over 5 years, duration of coughing, physical examination findings, pulmonary function and bronchial hyperresponsiveness to inhaled methacholine were retrospectively assessed.
Results: Of these patients with CVA, 10 developed the asthmatic symptoms of wheezing and dyspnea (precursors of classical asthma) over 5 years. All these 10 patients showed marked bronchial hyperresponsiveness; however, there were no significant differences in the bronchial responsiveness to methacholine between patients with precursors of classical asthma and pure CVA patients who did not wheeze. The duration of coughing had a significant relationship with precursors of classical asthma. Seven patients with precursors of classical asthma developed wheezing in the first year and 1 patient each in the second, third and fourth year.
Conclusions: These findings of a 5-year observation suggest that longer duration of coughing may be an important factor that develops precursors of classical asthma in patients with CVA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000087459 | DOI Listing |
J Colloid Interface Sci
January 2025
Collaborative Innovation Center of Sustainable Energy Materials, School of Physical Science and Technology, Guangxi University, Guangxi Key Laboratory of Electrochemical Energy Materials, State Key Laboratory of Featured Metal Materials and Life-cycle Safety for Composite Structures, Nanning 530004, China. Electronic address:
Transition metal-nitrogen-carbon (MNC) based on 3d metal atoms as promising non-precious metal catalysts have been extensively exploited for oxygen reduction reaction (ORR), but MNC with 4f rare earth metals have been largely ignored, most likely due to their large atomic radii that are difficult to coordinate with N dopants using conventional precursors. Herein, atomically dispersed dysprosium-nitrogen-carbon (DyNC) nanosheets were developed via the pyrolysis of anitrogen-containing chelate compound of 2, 4, 6-Tri (2-pyridyl) 1, 3, 5-triazine (TPTZ) ligand with Dy under the assistance of molten NaCl. The as-synthesized DyNC features specific moieties of single Dy atom coordinated by N and O as active sites for ORR, displaying excellent performance.
View Article and Find Full Text PDFBackground: Mild cognitive impairment (MCI) is viewed as a transitional stage between normal aging and Alzheimer's disease (AD), serving as a pathological precursor to AD. Longitudinal studies indicate an annual conversion rate from MCI to AD of 10-15%. Our previous studies have shown decreased coherence values in visual event-related slow frequency bands including theta frequency.
View Article and Find Full Text PDFBMC Biol
January 2025
Institute of Biology Leiden, Leiden University, Sylvius Laboratory, Sylviusweg 72, 2333 BE, Leiden, The Netherlands.
Background: Regeneration is the replacement of lost or damaged tissue with a functional copy. In axolotls and zebrafish, regeneration involves stem cells produced by de-differentiation. These cells form a growth zone which expresses developmental patterning genes at its apex.
View Article and Find Full Text PDFAlzheimers Dement
January 2025
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Introduction: Plaques are a hallmark feature of Alzheimer's disease (AD). We found that the loss of mucosal-associated invariant T (MAIT) cells and their antigen-presenting molecule MR1 caused a delay in plaque pathology development in AD mouse models. However, it remains unknown how this axis is impacting dystrophic neurites.
View Article and Find Full Text PDFPharmaceutics
November 2024
State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, Zhivopisnaya Str., Bld. 46, 123098 Moscow, Russia.
Background: Radiochemical purity is a key criterion for the quality of radiopharmaceuticals used in clinical practice. The joint improvement of analytical methods capable of identifying related radiochemical impurities and determining the actual radiochemical purity, as well as the improvement of synthesis methods to minimize the formation of possible radiochemical impurities, is integral to the implementation of high-tech nuclear medicine procedures. PSMA-targeted radionuclide therapy with lutetium-177 has emerged as an effective treatment option for prostate cancer, and [Lu]Lu-PSMA-617 and [Lu]Lu-PSMA have achieved global recognition as viable radiopharmaceuticals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!